NeuroOne Medical Technologies Corporation (NMTC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 11:03AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 28.89M |
| Enterprise Value | 26.58M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.32 |
| Price/Book (mrq) | 7.50 |
| Enterprise Value/Revenue | 7.13 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.06 |
| 52-Week Change 3 | -7.08% |
| S&P500 52-Week Change 3 | 28.04% |
| 52 Week High 3 | 2.0000 |
| 52 Week Low 3 | 0.8500 |
| 50-Day Moving Average 3 | 1.1552 |
| 200-Day Moving Average 3 | 1.1745 |
Share Statistics
| Avg Vol (3 month) 3 | 197.49k |
| Avg Vol (10 day) 3 | 206.43k |
| Shares Outstanding 5 | 27.52M |
| Implied Shares Outstanding 6 | 25.93M |
| Float 8 | 19.52M |
| % Held by Insiders 1 | 12.09% |
| % Held by Institutions 1 | 25.76% |
| Shares Short (Apr 30, 2024) 4 | 278.64k |
| Short Ratio (Apr 30, 2024) 4 | 1.73 |
| Short % of Float (Apr 30, 2024) 4 | 1.12% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 1.07% |
| Shares Short (prior month Mar 28, 2024) 4 | 365.33k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:3 |
| Last Split Date 3 | Apr 01, 2021 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Sept 30, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -346.80% |
Management Effectiveness
| Return on Assets (ttm) | -109.49% |
| Return on Equity (ttm) | -214.01% |
Income Statement
| Revenue (ttm) | 2.82M |
| Revenue Per Share (ttm) | 0.14 |
| Quarterly Revenue Growth (yoy) | -37.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | -13.34M |
| Net Income Avi to Common (ttm) | -13.47M |
| Diluted EPS (ttm) | -0.6800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.68M |
| Total Cash Per Share (mrq) | 0.1 |
| Total Debt (mrq) | 153.72k |
| Total Debt/Equity (mrq) | 3.48% |
| Current Ratio (mrq) | 3.68 |
| Book Value Per Share (mrq) | 0.18 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13.2M |
| Levered Free Cash Flow (ttm) | -8.61M |
© 2024 Yahoo. All rights reserved.